Biology Reference
In-Depth Information
Wang C, Li JF, Zhao L, Liu J, Wan J, Wang YX, Wang J (2009) Inhibition of SOC/Ca2+/NFAT
pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth
muscle cells. Respir Res 10:123
Wharton J, Strange JW, Moller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR
(2005) Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary
artery cells. Am J Respir Crit Care Med 172:105-113
Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, Bohm M, Sybrecht GW (2001)
Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.
Circulation 104:1218-1222
Yan C, Miller CL, Abe J (2007) Regulation of phosphodiesterase 3 and inducible cAMP early
repressor in the heart. Circ Res 100:489-501
Zaccolo M, Movsesian MA (2007) cAMP and cGMP signaling cross-talk: role of phosphodies-
terases and implications for cardiac pathophysiology. Circ Res 100:1569-1578
ZhangL,MurrayF,ZahnoA,KanterJR,ChouD,SudaR,FenlonM,RassentiL,CottamH,KippsTJ,
Insel PA (2008) Cyclic nucleotide phosphodiesterase profiling reveals increased expression of
phosphodiesterase 7B in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 105:19532-19537
Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM,
Aldashev A, Wilkins MR (2001) Sildenafil inhibits hypoxia-induced pulmonary hypertension.
Circulation 104:424-428
Zhu S, White RE, Barman SA (2008) Role of phosphodiesterases in modulation of BKCa channels
in hypertensive pulmonary arterial smooth muscle. Ther Adv Respir Dis 2:119-127
